This report from ISR provides insight into current bioanalytical lab activities, the anticipated increase in demand for these services through 2015, outsourcing market dynamics, as well as a historical service quality analysis for 17 bioanalytical lab service providers.

1. Bioanalytical Labs
Market Dynamics
and Service Provider
Performance
Info@ISRreports.com
©2013 Industry Standard Research www.ISRreports.com
PREVIEW

2. www.ISRreports.com ©2013 | Preview of: Bioanalytical Labs Market Dynamics and Service Provider Performance 2
act with confidence
Report Overview
100
Respondents
107Pages
135
Charts and
Graphs
Q3,
2013
Publication Date
Regions Analyzed:
ISR’s report provides insight into current bioanalytical lab activities, the anticipated increase in demand for
these services through 2015, outsourcing market dynamics, as well as a historical service quality analysis
for 17 bioanalytical lab service providers.
69%
North
America
25%
Europe
1%
China
3%
India
1%
Asia-Pacific
32% Executive Management
31% Clinical Operations
15% R&D Management
11% Medical
5% Drug Discovery
4% Preclinical Product Development
2% Other
Respondent Areas of Responsibility:
Performance Attributes Measured:
Companies Included:
Absorption Systems
Advion/ Quintiles
BASi
Celerion
Charles River
Covance
Eurofins/ Medinet
Frontage
ICON
Intertek
Lambda
MicroConstants
Medpace
MPI Research
Nuvisan
PAREXEL
Pharma Medica
inVentiv Health Clinical
PPD
PRA
QPS
Quotient Bioresearch
Ricerca
SGS
Tandem Labs (LabCorp)
Veeda
Worldwide Clinical Trials
WuXi
Analytical Resources
Assay Development Expertise
Biomarker Capabilities
Flexibility in Reporting and Data
Management
Geographic Coverage
Innovative Pricing Models
Low Cost
Method Development Turnaround
Time
On-time Delivery of Sample
analysis Data Files
PM and Technical Staff
Communication Responsiveness
Technical Expertise

3. www.ISRreports.com ©2013 | Preview of: Bioanalytical Labs Market Dynamics and Service Provider Performance 3
act with confidence
Report Overview
What You Will Learn in This Report:
• Current and future changes in the demand for
numerous small and large molecule tests across
discovery and preclinical, clinical development, and
post-commercialization
• Geographic locations and distribution of bioanalytical
lab spending across test categories
• Environment for bioanalytical lab outsourcing,
including: data on preferred providers, spending
distribution across large CROs, niche lab providers,
and in-house sponsor labs
• Most important attributes sponsor companies use to
select bioanalytical lab providers
• Historical performance evaluations of 17 leading
bioanalytical lab companies across key service
delivery components
How You Can Use This Report:
Sponsors:
• Evaluate and select bioanalytical lab providers by
relying on peer-based service quality ratings
• Shore up resources in anticipation for future growth in
demand for bioanalytical services
• Establish partnership synergies by selecting a
Bioanalytical lab provider that fits your organizational
needs
Service Providers:
• Position resources to capitalize on the anticipated
growth of bioanalytical lab services
• Quantify sponsors’ awareness, use, and preference for
17 bioanalytical lab service providers
• Differentiate your services by identify criteria sponsors
use to select bioanalytical lab providers
• Utilize pastcustomer satisfaction ratings from a
third-party source to identify operational and process
improvements and position your organization against
competitors
Major Sections:
1. Executive Summary: In this section ISR summarizes
the key findings and develops implications and
recommendations for sponsor and service provider
organizations.
2. Test Capabilities & Trends: Gauges the current
and future change in the need for numerous
small and large molecule tests across discovery
and preclinical, clinical development, and post-
commercialization. This section also identifies current
and future geographic locations for bioanalytical
tests and provides current and future distribution of
bioanalytical lab spending across test categories.
3. Outsourcing Environment: Outlines the current
environment for bioanalytical lab outsourcing and
includes data on preferred providers, spending
distribution across large CROs, niche lab providers,
and in-house sponsor labs.
4. Service Provider Selection: Details the most
important attributes sponsor companies use to select
bioanalytical lab providers across mass spectrometry
and immunochemistry services.
5. Service Provider Perception & Performance:
Provides sponsors and service providers with a view
into the performance of seventeen (17) leading
bioanalytical lab companies across key service
delivery components.
6. Cross-Service Provider Performance: Data are
presented by the key attributes used to measure
bioanalytical lab vendor quality and performance
for the eight (8) labs that received full profiles (based
on the number of interactions captured during the
research).
7. Service Provider Drill-downs: This section
provides a one-page summary of vendor familiarity
and performance for each of the twenty-eight (28)
bioanalytical lab providers included in the research.
8. Respondent Demographics: Provides the
reader with an understanding of the demographics
(company type, geographic location, phase
responsibility, roles and responsibility, job level, etc.)
for the 100 respondents.

4. www.ISRreports.com ©2013 | Preview of: Bioanalytical Labs Market Dynamics and Service Provider Performance 4
act with confidence
Table of Contents
Full table of contents and additional sample pages available in the full preview,
free on our website:
http://www.isrreports.com/product/bioanalytical-labs-market-dynamics-and-
service-provider-performance/

5. www.ISRreports.com ©2013 | Preview of: Bioanalytical Labs Market Dynamics and Service Provider Performance 5
act with confidence
www.isrreports.com
©2013|
EDC-­‐ePRO
Market
Trends
and
Service
Provider
Performance
26
5%
5%
4%
5%
6%
20%
14%
11%
6%
11%
50%
43%
39%
40%
31%
25%
38%
46%
49%
52%
0%
20%
40%
60%
80%
100%
Integra[on
capabili[es
with
other
applica[ons
(ePRO,
IVR)
Technical
support
from
the
vendor
The
process
for
dealing
with
queries
Speed
of
the
applica[ons,
how
fast
the
pages
load
Human-­‐machine
interface
(how
intui[ve
the
soeware
is
to
operate)
No
impact
Slight
impact
Moderate
impact
High
impact
EDC Operational Improvements
Most impactful EDC product attributes for trial success
“For each of the EDC product attributes below, please indicate how much impact each
has on your ability to successfully run a clinical trial that uses an EDC application.”
(Base
=
100)
Of
the
list
of
attributes
provided,
respondents
indicate
that
“technical
support”
and
“integration
capabilities”
had
less
of
an
impact
on
running
clinical
trial
when
compared
to
the
software
performance.
© 2013 Industry Standard Research
Sample Page
Introduction
The bioanalytical lab market is highly fragmented. Not only is this work
being done by a myriad of in-house labs and with outside service providers,
but the services performed cross both preclinical and clinical development.
There are very few types of operations or services that impact both the
preclinical and clinical development activities for a compound as much as
bioanalytical labs do. And the need for these services is growing.
Not one of the services ISR tested in this research is expected to decline
in activity over the next two years. Initially ISR hypothesized that, if we saw
a growing market, it would be attributed to the growing number of large
molecules in the development pipelines. However, these survey data show
that growth is anticipated for both small molecule and large molecule tests.
The market dynamics that surround bioanalytical lab services are not unlike
those of the general clinical development market, albeit with a higher
percentage of outsourcing than clinical development overall. What we find
is that the majority of this activity is outsourced, but not to the extent of
central lab activities, that sponsors do not have an overwhelming preference
for large, multi-service CROs vs. niche providers, and that many of the
outsourcing decisions are driven by preferred provider agreements.
The purpose of this report is to give both sponsors and bioanalytical lab
service providers a view into the current and future market landscape and
provide an objective review of service provider performance. These data can
be used to plan for future resource requirements, to develop outsourcing
strategies, to inform tactical/ operational and strategic planning, to enhance
service offerings, and for organizational benchmarking.
This report includes topline data on 28 bioanalytical lab service providers,
performance is highlighted for 17 providers based on the number of
responses received for each, and eight (8) of the leading providers are
profiled in a cross attribute manner. In total, this research captures 289
service encounters.

6. www.ISRreports.com ©2013 | Preview of: Bioanalytical Labs Market Dynamics and Service Provider Performance 6
act with confidence
Sample Page
www.isrreports.com
©2013|
Bioanalytical
Labs:
Market
Dynamics
and
Service
Provider
Performance
22
24%
31%
36%
32%
26%
8%
9%
6%
5%
4%
57%
46%
43%
44%
40%
11%
14%
15%
19%
30%
0% 20% 40% 60% 80% 100%
Proprietary biomarker sample analysis
Quantitative LC/MS/MS
Therapeutic drug monitoring (post-
commercialization)
Companion diagnostic development
Biomarker discovery
No Need Declining Need No Change Increasing Need
Post-Commercialization
24%
31%
36%
32%
26%
8%
9%
6%
5%
4%
57%
46%
43%
44%
40%
11%
14%
15%
19%
30%
0% 20% 40% 60% 80% 100%
Proprietary biomarker sample analysis
Quantitative LC/MS/MS
Therapeutic drug monitoring (post-
commercialization)
Companion diagnostic development
Biomarker discovery
No Need Declining Need No Change Increasing Need
Post-Commercialization
Future change in small molecule tests need
“For small molecules, please indicate how your need for each of the services
listed below will change over the next two years based on the stage of com-
pound development?” (Base = 100)

7. www.ISRreports.com ©2013 | Preview of: Bioanalytical Labs Market Dynamics and Service Provider Performance 7
act with confidence
Sample Page
www.isrreports.com
©2013|
Bioanalytical
Labs:
Market
Dynamics
and
Service
Provider
Performance
54
2%
0%
0%
6%
0%
10%
10%
4%
4%
0%
2%
12%
10%
6%
14%
45%
12%
10%
12%
6%
73%
65%
67%
63%
67%
71%
43%
67%
67%
57%
59%
18%
22%
20%
18%
27%
4%
2%
12%
14%
24%
27%
4%
2%
6%
6%
4%
4%
6%
8%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Analytical resources
Assay development expertise
Biomarker capabilities
Flexibility in reporting and data management
Geographic coverage
Innovative pricing models
Low cost
Method development turnaround time
On-time delivery of sample analysis data files
PM and technical staff communication responsiveness
Technical expertise
Greatly fell short of my expectations Somewhat fell short of my expectations
Met my expectations Somewhat exceeded my expectations
Greatly exceeded my expectations
Covance
(Base = 49)
Sample Service Provider Profile

8. www.ISRreports.com ©2013 | Preview of: Bioanalytical Labs Market Dynamics and Service Provider Performance 8
act with confidence
Sample Page
Full table of contents and additional sample pages available in the full preview,
free on our website:
http://www.isrreports.com/product/bioanalytical-labs-market-dynamics-and-
service-provider-performance/

9. www.ISRreports.com ©2013 | Preview of: Bioanalytical Labs Market Dynamics and Service Provider Performance 9
act with confidence
Ordering Information
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma
and pharma services industries. With over a decade of experience in the industry, ISR delivers an un-
matched level of domain expertise.
For more information about our off-the-shelf intelligence and custom research offerings, please visit
our Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.
About Industry Standard Research
Pricing and ordering information is available on our website:
http://www.isrreports.com/product/bioanalytical-labs-market-dynamics-and-
service-provider-performance/